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counterpulsation during this period of CPB reduces after- 
load and also improves myocardial oxygen delivery. 7 An- 
other potential benefit of IAB counterpulsation during 
CPB is pulsatile perfusion. The use of IAB counterpulsa- 
tion as a simple method of achieving pulsatile flow during 
CPB was elucidated by Pappas and associates 7 in 1975. 
This may result in better organ function 8" 9 by the mech- 
anism, not simply because of pulsatile flow but as an effect 
of the passive distention of the peripheral vascular bed 
owing to the propagation of the IAB-augmented diastolic 
pressure through the arterial system, m Combining IAB 
counterpulsation and CPB fulfils the need for greater 
hemodynamic support by pulsatile flow during diastole 
and unloading of the left ventricle during systole, a~ The 
patients in whom the use of IAB pumping is indicated 
before the operation are in a low cardiac output state. The 
renal and gastrointestinal perfusion in many of these 
patients is also suboptimal. Over recent years the impor- 
tance of gastrointestinal perfusion has been more widely 
recognized with regard to patients in shock. 12 lAB coun- 
terpulsation may help to reduce CPB-induced gut mucosal 
hypoperfusion, thus avoiding intestinal ischemia nd sub- 
sequent endotoxemia. 
Today the IAB pump is the most widely used circulatory 
assist device. Improvement in its ease of insertion, safety, 
rapid applicability, and ability to provide adequate sup- 
port in a low cardiac output syndrome has widened its use. 
IAB counterpulsation is an effective method of protecting 
the myocardium in the perioperative period and reducing 
organ dysfunction during CPB. However, as our survey 
revealed, the majority of cardiac surgeons in the United 
Kingdom do not fully use the benefits of IAB pulsatility 
during CPB. On the basis of available literature, we 
advocate continued counterpulsation during the whole 
of CPB. 
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To the Editor." 
On July 16, 1997, I replaced a Hancock porcine valve 
implanted in the mitral position on August 4, 1976, by Dr. 
Frank Johnston at our institution. It had been in place 20 
years, 345 days. The leaflets were heavily calcified, and 
there was a perforation at the base of one of the leaflets. 
The valve was replaced with a No. 29 Hancock Medtronic 
prosthesis (Medtronic, Inc., Minneapolis, Minn.). 
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